J&J, Bristol Myers lose challenges to US drug price negotiation programme

Bristol Myers Squibb خبریں

J&J, Bristol Myers lose challenges to US drug price negotiation programme
Johnson & Johnson. J&JBlood Clot Prevention DrugsMedicare
  • 📰 DunyaNews
  • ⏱ Reading Time:
  • 50 sec. here
  • 13 min. at publisher
  • 📊 Quality Score:
  • News: 61%
  • Publisher: 83%

A federal judge rules they were free to stop participating in Medicare

Blood thinners Eliquis and Xarelto were among the 10 drugs chosen last August for the first round of talks

US District Judge Zahid Quraishi in Trenton, New Jersey, became the fourth federal judge to uphold the programme, one of Democratic President Joe Biden's signature initiatives, against drug industry challenges, rejecting their argument that it was an illegal taking of their property. The drugmakers did not immediately respond to requests for comment, though Bristol Myers has already filed a notice in court that it was appealing the ruling. Drugmakers have argued that it is not feasible to withdraw from Medicare because it represents nearly half the US prescription drug market.

Eliquis brought Bristol Myers about $8.52 billion in US sales last year, while J&J recorded $2.36 billion in Xarelto sales.Quraishi's ruling comes two days before a conservative-leaning panel of the 5th US Circuit Court of Appeals hears an appeal by PhRMA, the leading US drug industry group, seeking to revive its lawsuit challenging the programme after it was dismissed in February.

ہم نے اس خبر کا خلاصہ کیا ہے تاکہ آپ اسے جلدی سے پڑھ سکیں۔ اگر آپ خبر میں دلچسپی رکھتے ہیں تو آپ مکمل متن یہاں پڑھ سکتے ہیں۔ مزید پڑھ:

DunyaNews /  🏆 1. in PK

Johnson & Johnson. J&J Blood Clot Prevention Drugs Medicare Health Insurance Programme Eliquis Xarelto Drug Prices Inflation Reduction Act Blood Thinners Biden Administration US Drug Industry

پاکستان تازہ ترین خبریں, پاکستان عنوانات

Similar News:آپ اس سے ملتی جلتی خبریں بھی پڑھ سکتے ہیں جو ہم نے دوسرے خبروں کے ذرائع سے جمع کی ہیں۔

US accuses Regeneron of fraudulent price reporting for eye drugUS accuses Regeneron of fraudulent price reporting for eye drugThe medication has a wholesale acquisition cost of $1,850 per vial.
مزید پڑھ »

WHO likely to issue wider alert on contaminated J&J cough syrupWHO likely to issue wider alert on contaminated J&J cough syrupWHO likely to issue wider alert on contaminated J&J cough syrup
مزید پڑھ »

US health officials investigate alleged pesticide contamination in India spices mixUS health officials investigate alleged pesticide contamination in India spices mixThe US Food and Drug Administration is investigating products made by two Indian spice makers for allegedly containing a cancer-causing
مزید پڑھ »

Ismat Zaidi says newcomers devoid of respect for seniorsIsmat Zaidi says newcomers devoid of respect for seniorsShe shed light on persistent challenges within the industry
مزید پڑھ »

Doctors run first human trial of growing new liver in patient's bodyDoctors run first human trial of growing new liver in patient's bodyThis groundbreaking approach offers solution to challenges posed by severe liver diseases
مزید پڑھ »

UN report urges funding in development investment to rescue SDGs; Pakistan calls it timelyUN report urges funding in development investment to rescue SDGs; Pakistan calls it timelyFinancing challenges are at the heart of the world’s sustainable development crisis
مزید پڑھ »



Render Time: 2025-02-24 08:16:57